Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee.
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
J Am Acad Dermatol. 2021 Jul;85(1):121-127. doi: 10.1016/j.jaad.2020.12.023. Epub 2020 Dec 14.
Low-dose total skin electron beam therapy provides a durable treatment response for skin lesions caused by cutaneous T-cell lymphoma. We prospectively assessed the durability of response and quality of life for patients receiving low-dose total skin electron beam therapy using a novel rotational technique and dosing regimen.
Patients completed baseline Skindex-29 quality-of-life surveys and had baseline Modified Severity-Weighted Assessment Tool score recorded. Patients received 12 Gy in 12 fractions with a dual-field rotational technique. The primary outcome was overall response rate, with the secondary outcomes being time to treatment response, duration of clinical benefit, and quality-of-life change.
We enrolled 20 patients and recorded an overall response rate of 90%. The median time to treatment response was 6.5 weeks. The baseline Modified Severity-Weighted Assessment Tool score was 55.6 and it declined to a median of 2.2 at last follow-up (P < .001). The median duration of clinical benefit was 21 months. There was a decline in the Skindex-29 total score and every subdomain when each follow-up visit was compared (P = .004).
This prospective study demonstrated a very high overall response rate and improvement in skin-related quality of life. Low-dose rotational total skin electron beam therapy can be implemented routinely in clinical practice.
低剂量全身电子束治疗可为皮肤 T 细胞淋巴瘤引起的皮肤病变提供持久的治疗反应。我们前瞻性评估了使用新型旋转技术和剂量方案接受低剂量全身电子束治疗的患者的反应持久性和生活质量。
患者完成基线 Skindex-29 生活质量调查,并记录基线改良严重程度加权评估工具评分。患者接受 12Gy 分 12 次,采用双野旋转技术。主要结局是总缓解率,次要结局是治疗反应时间、临床获益持续时间和生活质量变化。
我们入组了 20 例患者,总缓解率为 90%。治疗反应的中位时间为 6.5 周。基线改良严重程度加权评估工具评分 55.6,最后一次随访时降至中位数 2.2(P <.001)。临床获益的中位持续时间为 21 个月。与每次随访时相比,Skindex-29 总分和每个子域都有所下降(P =.004)。
这项前瞻性研究表明,总缓解率非常高,皮肤相关生活质量得到改善。低剂量旋转全身电子束治疗可常规应用于临床实践。